Sign In

Prevention of HIV.

HIV Question Bank

Preventing Perinatal HIV TransmissionQuestion 2/15

Questions in Topic

A 37-year-old cisgender woman with HIV is seen for follow-up for the management of HIV during pregnancy. She is approximately 13 weeks’ gestation and was diagnosed with HIV 2 years ago. She is currently taking tenofovir DF-emtricitabine plus dolutegravir, and recent laboratory studies showed an HIV RNA level below the limit of detection.

Which one of the following is recommended as part of laboratory monitoring during pregnancy for this woman with HIV?

Prev  Skip

Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Question Last Updated
June 7th, 2024

Steps to Acquire CE for this Question Bank Topic:

1

Answer

Answer all questions
2

Score 80%+

Answer correctly
3

Claim CE

Choose CNE or CME
4

Give Feedback

Complete survey
5

Print Certificate

Obtain proof of CE

This question requires improvement because:


Comment further on how to improve this question or summary:



Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.